Novel, objective, multivariate biomarkers composed of plasma amino acid profiles for the diagnosis and assessment of inflammatory bowel disease

PLoS ONE

Volumn 7, Issue 1, 2012, Pages

  Hisamatsu, Tadakazu ^a   Okamoto, Susumu ^a   Hashimoto, Masaki ^c   Muramatsu, Takahiko ^c   Andou, Ayatoshi ^c   Uo, Michihide ^c   Kitazume, Mina T ^a   Matsuoka, Katsuyoshi ^a   Yajima, Tomoharu ^a   Inoue, Nagamu ^a   Kanai, Takanori ^a   Ogata, Haruhiko ^a   Iwao, Yasushi ^a   Yamakado, Minoru ^b   Sakai, Ryosei ^c   Ono, Nobukazu ^c   Ando, Toshihiko ^c   Suzuki, Manabu ^c   Hibi, Toshifumi ^a  

^a KEIO UNIVERSITY   (Japan)

^b MITSUI MEMORIAL HOSPITAL   (Japan)

^c AJINOMOTO CO INC   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; AMINO ACID; ARGININE; ASPARAGINE; BIOLOGICAL MARKER; CITRULLINE; CYSTINE; GLUTAMIC ACID; GLUTAMINE; GLYCINE; HISTIDINE; ISOLEUCINE; LEUCINE; LYSINE; METHIONINE; ORNITHINE; PHENYLALANINE; PROLINE; SERINE; TAURINE; THREONINE; TRYPTOPHAN; TYROSINE; VALINE;

ADULT; AMINO ACID BLOOD LEVEL; AREA UNDER THE CURVE; ARTICLE; CLINICAL ASSESSMENT TOOL; CONTROLLED STUDY; CROHN DISEASE; DIET RESTRICTION; DISEASE ACTIVITY; ENTERITIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT MONITORING; PLASMA AMINOGRAM; RECEIVER OPERATING CHARACTERISTIC; REMISSION; SENSITIVITY AND SPECIFICITY; ULCERATIVE COLITIS; BLOOD; CASE CONTROL STUDY; DISEASE COURSE; METABOLISM; MULTIVARIATE ANALYSIS; NONPARAMETRIC TEST; PATHOLOGY;

ADULT; AMINO ACIDS; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; COLITIS, ULCERATIVE; CROHN DISEASE; DISEASE PROGRESSION; FEMALE; HISTIDINE; HUMANS; INFLAMMATORY BOWEL DISEASES; MALE; MULTIVARIATE ANALYSIS; STATISTICS, NONPARAMETRIC; TRYPTOPHAN;

EID: 84856420259     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0031131     Document Type: Article

References (28)

1. Hibi T, Ogata H, (2006) Novel pathophysiological concepts of inflammatory bowel disease. J Gastroenterol 41: 10-16.
2. Xavier RJ, Podolsky DK, (2007) Unravelling the pathogenesis of inflammatory bowel disease. Nature 448: 427-434.
3. Felig P, (1975) Amino acid metabolism in man. Annu Rev Biochem 44: 933-955.
4. Brosnan JT, (2003) Interorgan amino acid transport and its regulation. J Nutr 133: 2068S-2072S.
5. Shiota T, Nakatsukasa H, Fujiwara M, Takei N, Yamauchi Y, et al. (1984) Plasma amino acid imbalance in alcoholic liver cirrhosis. Biochem Med 32: 181-188.
6. Holm E, Sedlaczek O, Grips E, (1999) Amino acid metabolism in liver disease. Curr Opin Clin Nutr Metab Care 2: 47-53.
7. Ferenci P, Wewalka F, (1978) Plasma amino acids in hepatic encephalopathy. J Neural Transm Suppl: 87-94.
8. Soeters PB, Fischer JE, (1976) Insulin, glucagon, aminoacid imbalance, and hepatic encephalopathy. Lancet 2: 880-882.
9. Maeda J, Higashiyama M, Imaizumi A, Nakayama T, Yamamoto H, et al. (2010) Possibility of multivariate function composed of plasma amino acid profiles as a novel screening index for non-small cell lung cancer: a case control study. BMC Cancer 10: 690.
10. Noguchi Y, Zhang QW, Sugimoto T, Furuhata Y, Sakai R, et al. (2006) Network analysis of plasma and tissue amino acids and the generation of an amino index for potential diagnostic use. Am J Clin Nutr 83: 513S-519S.
11. Winship DH, Summers RW, Singleton JW, Best WR, Becktel JM, et al. (1979) National Cooperative Crohn's Disease Study: study design and conduct of the study. Gastroenterology 77: 829-842.
12. Lichtiger S, Present DH, Kornbluth A, Gelernt I, Bauer J, et al. (1994) Cyclosporine in severe ulcerative colitis refractory to steroid therapy. N Engl J Med 330: 1841-1845.
13. Puccetti P, Grohmann U, (2007) IDO and regulatory T cells: a role for reverse signalling and non-canonical NF-kappaB activation. Nat Rev Immunol 7: 817-823.
14. Munn DH, Zhou M, Attwood JT, Bondarev I, Conway SJ, et al. (1998) Prevention of allogeneic fetal rejection by tryptophan catabolism. Science 281: 1191-1193.
15. Romani L, Fallarino F, De Luca A, Montagnoli C, D'Angelo C, et al. (2008) Defective tryptophan catabolism underlies inflammation in mouse chronic granulomatous disease. Nature 451: 211-215.
16. Forrest CM, Gould SR, Darlington LG, Stone TW, (2003) Levels of purine, kynurenine and lipid peroxidation products in patients with inflammatory bowel disease. Adv Exp Med Biol 527: 395-400.
17. Wolf AM, Wolf D, Rumpold H, Moschen AR, Kaser A, et al. (2004) Overexpression of indoleamine 2,3-dioxygenase in human inflammatory bowel disease. Clin Immunol 113: 47-55.
18. Gerber DA, (1975) Low free serum histidine concentration in rheumatoid arthritis. A measure of disease activity. J Clin Invest 55: 1164-1173.
19. Watanabe M, Suliman ME, Qureshi AR, Garcia-Lopez E, Barany P, et al. (2008) Consequences of low plasma histidine in chronic kidney disease patients: associations with inflammation, oxidative stress, and mortality. Am J Clin Nutr 87: 1860-1866.
20. Pinals RS, Harris ED, Burnett JB, Gerber DA, (1977) Treatment of rheumatoid arthritis with L-histidine: a randomized, placebo-controlled, double-blind trial. J Rheumatol 4: 414-419.
21. Akobeng AK, Thomas AG, (2007) Enteral nutrition for maintenance of remission in Crohn's disease. Cochrane Database Syst Rev pp. CD005984.
22. Andou A, Hisamatsu T, Okamoto S, Chinen H, Kamada N, et al. (2009) Dietary histidine ameliorates murine colitis by inhibition of proinflammatory cytokine production from macrophages. Gastroenterology 136: 564-574 e562.
23. Wall AJ, Kirsner JB, (1975) Ulcerative colitis and Crohn's disease of the colon: Symptoms, signs, and laboratory aspects. In: Kirsner JB, Shorter RG, editors. pp. 101-108 Inflammatory Bowel Disease Lea & Febiger, Philadelphia.
24. Vernier G, Sendid B, Poulain D, Colombel JF, (2004) Relevance of serologic studies in inflammatory bowel disease. Curr Gastroenterol Rep 6: 482-487.
25. Targan SR, Landers CJ, Yang H, Lodes MJ, Cong Y, et al. (2005) Antibodies to CBir1 flagellin define a unique response that is associated independently with complicated Crohn's disease. Gastroenterology 128: 2020-2028.
26. Dotan I, Fishman S, Dgani Y, Schwartz M, Karban A, et al. (2006) Antibodies against laminaribioside and chitobioside are novel serologic markers in Crohn's disease. Gastroenterology 131: 366-378.
27. Langhorst J, Elsenbruch S, Koelzer J, Rueffer A, Michalsen A, et al. (2008) Noninvasive markers in the assessment of intestinal inflammation in inflammatory bowel diseases: performance of fecal lactoferrin, calprotectin, and PMN-elastase, CRP, and clinical indices. Am J Gastroenterol 103: 162-169.
28. Vermeire S, Van Assche G, Rutgeerts P, (2004) C-reactive protein as a marker for inflammatory bowel disease. Inflamm Bowel Dis 10: 661-665.